Gracell Biotechnologies Inc. Stock
Equities
GRCL
US38406L1035
Biotechnology & Medical Research
Latest transcript on Gracell Biotechnologies Inc.
Managers | Title | Age | Since |
---|---|---|---|
Wei Cao
CEO | Chief Executive Officer | 66 | 17-04-30 |
Yi Li Xie
DFI | Director of Finance/CFO | 54 | 20-07-23 |
Wendy Li
CTO | Chief Tech/Sci/R&D Officer | 66 | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Cao
CEO | Chief Executive Officer | 66 | 17-04-30 |
Guo Tong Xu
BRD | Director/Board Member | 67 | 19-01-31 |
Guo Wei Wang
BRD | Director/Board Member | 63 | 20-02-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 117 M€ | +1.11% | - |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.59B | |
+8.57% | 40.65B | |
+49.22% | 40.57B | |
-12.36% | 26.77B | |
+8.92% | 24.81B | |
-25.13% | 18.17B | |
+29.17% | 12.05B | |
-3.12% | 11.7B | |
+6.35% | 11.1B |